|
Index of reports
> Cases resulting in other serious reactions (345)
> Cases with Convulsion (24)
Below is the selection of adverse event reports related to Topamax (Topiramate) that includes cases resulting in other serious reactions where reactions include convulsion.
Adverse event in 69 year old male receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: 69 year old male, weighing 70.3 kg (154.7 pounds)
Adverse reactions / side effects: Palpitations, Mouth Breathing, Tongue DRY, Rash, Fall, Convulsion, Eye Pain
Suspect drug(s):
Topamax
Administration route: Oral
Topamax
Administration route: Oral
Topamax
Dosage: 75 mg in am; 75 mg in pm
Administration route: Oral
Topamax
Dosage: 50 mg in am; 75 mg in pm
Administration route: Oral
Indication: Convulsion
Other drugs received by patient: Lamictal; Lamictal; Keppra; Vitamins; Vitamin D; Aspirin
Adverse event in male receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United Kingdom on 2007-10-05
Patient: male, weighing 18.2 kg (40.0 pounds)
Adverse reactions / side effects: Drooling, Rash, Drug Prescribing Error, Epilepsy, Aggression, Convulsion, Mood Swings, Muscle Spasms
Suspect drug(s):
Topamax
Topamax
Indication: Epilepsy
Other drugs received by patient: Valproate Sodium
Adverse event in receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-07-25
Patient: , weighing 48.5 kg (106.8 pounds)
Adverse reactions / side effects: Asthma, Sleep Disorder, Sedation, Hemiparesis, Convulsion
Suspect drug(s):
Topamax
Indication: Migraine
Topamax
Indication: Convulsion
Adverse event in female receiving Topamax (Topiramate)
Reported by a individual with unspecified qualification from United States on 2007-07-17
Patient: female, weighing 85.5 kg (188.0 pounds)
Adverse reactions / side effects: Weight Increased, Concussion, Head Injury, Fall, Convulsion
Suspect drug(s):
Keppra
Indication: Migraine
Keppra
Indication: Partial Seizures
Lyrica
Indication: Migraine
Lyrica
Indication: Partial Seizures
Topamax
Indication: Migraine
Topamax
Indication: Partial Seizures
Other drugs received by patient: Maxalt-MLT
Adverse event in female receiving Topamax (Topiramate)
Reported by a pharmacist from United States on 2007-07-11
Patient: female
Adverse reactions / side effects: Drug Interaction, Convulsion
Suspect drug(s):
Topamax (Topiramate)
Other drugs received by patient possibly interacting with the suspect drug:
Chantix
Chantix
Indication: Smoking Cessation Therapy
Other drugs received by patient: Nexium; Premarin; Cymbalta; Methadone HCL
Adverse event in female receiving Topamax (Topiramate)
Reported by a pharmacist from Canada on 2007-06-29
Patient: female
Adverse reactions / side effects: Drug Dispensing Error, Convulsion
Suspect drug(s):
Topamax
Topamax
Indication: Drug USE FOR Unknown Indication
Adverse event in 26 year old female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-06-26
Patient: 26 year old female, weighing 56.2 kg (123.8 pounds)
Adverse reactions / side effects: Irritability, Dyspnoea, Palpitations, Underdose, Disorientation, Lethargy, Convulsion
Suspect drug(s):
Topamax
Administration route: Oral
Topamax
Administration route: Oral
Topamax
Administration route: Oral
Topamax
Dosage: titrated up to 200 mg daily
Administration route: Oral
Topamax
Administration route: Oral
Indication: Epilepsy
Other drugs received by patient: Femchew
Adverse event in 15 year old female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-06-13
Patient: 15 year old female
Adverse reactions / side effects: Weight Decreased, Educational Problem, Abnormal Behaviour, Drug Dispensing Error, Somnolence, Convulsion
Suspect drug(s):
Lamictal
Dosage: 25mg unknown
Topamax
Dosage: 25mg unknown
Adverse event in female receiving Topamax (Topiramate)
Reported by a physician from Germany on 2007-06-07
Patient: female
Adverse reactions / side effects: Electrocardiogram Change, Convulsion
Suspect drug(s):
Topamax (Topiramate)
Adverse event in 34 year old female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-05-22
Patient: 34 year old female, weighing 45.4 kg (99.8 pounds)
Adverse reactions / side effects: Weight Decreased, Drug Effect Increased, Visual Disturbance, Memory Impairment, Convulsion, Loss of Consciousness
Suspect drug(s):
Topamax (Topiramate)
Adverse event in female receiving Topamax (Topiramate)
Reported by a pharmacist from United States on 2007-05-11
Patient: female
Adverse reactions / side effects: Drug Interaction, Convulsion
Suspect drug(s):
Topamax (Topiramate)
Other drugs received by patient possibly interacting with the suspect drug:
Chantix
Indication: Smoking Cessation Therapy
Other drugs received by patient: Nexium; Premarin; Cymbalta; Methadone HCL
Adverse event in male receiving Topamax (Topiramate)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-10
Patient: male, weighing 69.4 kg (152.7 pounds)
Adverse reactions / side effects: Anxiety, Inappropriate Schedule of Drug Administration, Haemoptysis, Pain, Tympanic Membrane Perforation, Pharmaceutical Product Complaint, Convulsion
Suspect drug(s):
Duragesic-100
Indication: Back Pain
Topamax
Administration route: Oral
Indication: Convulsion
Other drugs received by patient: Oxycontin
Adverse event in 3 year old male receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-05-07
Patient: 3 year old male
Adverse reactions / side effects: Blood Glucose Decreased, Nuclear Magnetic Resonance Imaging Abnormal, Convulsion
Adverse event resulted in: hospitalization
Suspect drug(s):
Claritin
Dosage: 5 ml;once;po
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2007-03-29
End date: 2007-03-29
Robitussin / 00048001 /
Dosage: 5 ml;once;po
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2007-03-29
End date: 2007-03-29
Topamax
Dosage: po
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Triaminic SRT
Dosage: 1 df;q6h;po
Administration route: Oral
Indication: Nasopharyngitis
Start date: 2006-11-01
End date: 2007-03-29
Adverse event in male receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-04-30
Patient: male, weighing 68.0 kg (149.7 pounds)
Adverse reactions / side effects: Anxiety, Inappropriate Schedule of Drug Administration, Haemoptysis, Pain, Tympanic Membrane Perforation, Convulsion
Suspect drug(s):
Duragesic-100
Indication: Back Pain
Topamax
Administration route: Oral
Indication: Convulsion
Other drugs received by patient: Oxycontin
Adverse event in 59 year old male receiving Topamax (Topiramate)
Reported by a individual with unspecified qualification from United States on 2007-04-19
Patient: 59 year old male, weighing 81.7 kg (179.6 pounds)
Adverse reactions / side effects: Weight Decreased, Fatigue, Malaise, Anorexia, Hypoglycaemia, Convulsion
Suspect drug(s):
Depakote
Indication: Convulsion
Lantus
Dosage: 14 u, qd
Indication: Diabetes Mellitus
Start date: 2006-04-01
Lantus
Dosage: 10 u, qd
Lantus
Dosage: 8 u, qd
Lantus
Dosage: 6 u, qd
Administration route: Oral
Start date: 2006-04-01
Starlix
Dosage: 120 mg, tid
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2006-06-02
End date: 2006-10-05
Starlix
Dosage: 120 mg, bid
Administration route: Oral
Start date: 2006-10-06
End date: 2006-12-22
Topamax
Dosage: 400 mg, qd
Start date: 2006-09-01
Other drugs received by patient: Januvia; Tricor; Trileptal; ^homocore^; ^lisciol^; Zetia
Adverse event in male receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-03-12
Patient: male, weighing 136.1 kg (299.4 pounds)
Adverse reactions / side effects: Confusional State, Weight Decreased, Autonomic Nervous System Imbalance, Body Temperature Increased, Pain, Libido Decreased, Headache, Amnesia, Convulsion, Weight Increased, Thinking Abnormal, Anhidrosis, Insomnia, Feeling Jittery, Eye Disorder
Adverse event resulted in: disablity
Suspect drug(s):
Topamax
Administration route: Oral
Topamax
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Aspirin; Vitamin CAP; Vicodin; Vicodin; Valium; Valium; Valium; Valium; Hydrocodone; Morphine
Adverse event in 18 year old female receiving Topamax (Topiramate)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-03-02
Patient: 18 year old female, weighing 37.0 kg (81.4 pounds)
Adverse reactions / side effects: Death, Medical Device Complication, Gastrointestinal Haemorrhage, Renal Failure, Oesophagitis, Sepsis, Treatment Noncompliance, Convulsion
Adverse event resulted in: death
Suspect drug(s):
Topamax
Topamax
Indication: Convulsion
Other drugs received by patient: Phenytoin; Levetorazepam; Valproate Sodium; Sedatives; Noradrenalin
Adverse event in male receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-02-21
Patient: male, weighing 68.0 kg (149.7 pounds)
Adverse reactions / side effects: Anxiety, Inappropriate Schedule of Drug Administration, Haemoptysis, Pain, Tympanic Membrane Perforation, Convulsion
Suspect drug(s):
Duragesic-100
Indication: Back Pain
Topamax
Administration route: Oral
Indication: Convulsion
Other drugs received by patient: Oxycontin
Adverse event in 60 year old female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-02-15
Patient: 60 year old female
Adverse reactions / side effects: Migraine, Weight Decreased, Drug Interaction, Headache, Amnesia, Convulsion, Poor Quality Sleep, Alopecia, Disturbance in Attention, Thyroid Neoplasm, Decreased Appetite
Suspect drug(s):
Topamax
Administration route: Oral
Indication: Migraine Prophylaxis
Start date: 2006-04-01
Valtrex
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Synthroid; Imitrex
Adverse event in 59 year old male receiving Topamax (Topiramate)
Reported by a individual with unspecified qualification from United States on 2007-02-12
Patient: 59 year old male, weighing 81.7 kg (179.6 pounds)
Adverse reactions / side effects: Weight Decreased, Fatigue, Malaise, Hypoglycaemia, Convulsion
Suspect drug(s):
Depakote
Indication: Convulsion
Lantus
Dosage: 14 u, qd
Indication: Diabetes Mellitus
Start date: 2006-04-01
Lantus
Dosage: 10 u, qd
Lantus
Dosage: 8 u, qd
Lantus
Dosage: 6 u, qd
Administration route: Oral
Starlix
Dosage: 120 mg, tid
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2006-06-02
End date: 2006-10-05
Starlix
Dosage: 120 mg, bid
Administration route: Oral
Start date: 2006-10-06
End date: 2006-12-22
Topamax
Dosage: 400 mg, qd
Start date: 2006-09-01
Other drugs received by patient: Januvia; Tricor; Trileptal; ^homocore^; ^lisciol^; Zetia
Adverse event in 60 year old female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-02-06
Patient: 60 year old female
Adverse reactions / side effects: Weight Decreased, Drug Ineffective, Drug Interaction, Headache, Amnesia, Convulsion, Poor Quality Sleep, Alopecia, Inadequate Diet, Disturbance in Attention, Thyroid Neoplasm
Suspect drug(s):
Topamax
Administration route: Oral
Topamax
Administration route: Oral
Indication: Migraine Prophylaxis
Other drugs received by patient possibly interacting with the suspect drug:
Valtrex
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Synthroid; Imitrex
Adverse event in male receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-02-01
Patient: male, weighing 40.8 kg (89.8 pounds)
Adverse reactions / side effects: Accident, Diarrhoea, Pancreatitis, Convulsion, Gastroenteritis Viral
Adverse event resulted in: hospitalization
Suspect drug(s):
Topamax
Administration route: Oral
Topamax
Administration route: Oral
Indication: Epilepsy
Other drugs received by patient: Lamictal; Ativan; Dyastat; Clorasap
Adverse event in 27 year old female receiving Topamax (Topiramate)
Reported by a consumer/non-health professional from United States on 2007-01-22
Patient: 27 year old female, weighing 100.7 kg (221.5 pounds)
Adverse reactions / side effects: Renal Impairment, Laboratory Test Abnormal, Metabolic Acidosis, Condition Aggravated, Convulsion
Suspect drug(s):
Topamax (Topiramate)
Adverse event in 59 year old male receiving Topamax (Topiramate)
Reported by a individual with unspecified qualification from United States on 2007-01-16
Patient: 59 year old male, weighing 81.7 kg (179.6 pounds)
Adverse reactions / side effects: Weight Decreased, Hypoglycaemia, Convulsion
Suspect drug(s):
Depakote
Indication: Convulsion
Lantus
Dosage: 14 u, qd
Indication: Diabetes Mellitus
Start date: 2006-04-01
Lantus
Dosage: 10 u, qd
Lantus
Dosage: 8 u, qd
Lantus
Dosage: 6 u, qd
Administration route: Oral
Starlix
Dosage: 125 mg, unk
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2006-04-01
Topamax
Dosage: 400 mg, qd
Start date: 2006-09-01
Other drugs received by patient: Januvia; Tricor; Trileptal; ^homocore^; ^lisciol^; Zetia
|
